Tugay, D. Et Al. 2023. Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey. JOURNAL OF MEDICAL ECONOMICS , vol.26 , 1-10.

Tugay, D., Top, M., Aydın, Ö., Bavbek, S., Damadoğlu, E., Erkekol, F. Ö., ... Koca Kalkan, İ.(2023). Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey. JOURNAL OF MEDICAL ECONOMICS , vol.26, 1-10.

Tugay, Deniz Et Al. "Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey," JOURNAL OF MEDICAL ECONOMICS , vol.26, 1-10, 2023

Tugay, Deniz Et Al. "Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey." JOURNAL OF MEDICAL ECONOMICS , vol.26, pp.1-10, 2023

Tugay, D. Et Al. (2023) . "Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey." JOURNAL OF MEDICAL ECONOMICS , vol.26, pp.1-10.

@article{article, author={Deniz Tugay Et Al. }, title={Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey}, journal={JOURNAL OF MEDICAL ECONOMICS}, year=2023, pages={1-10} }